Expansion and Activation of CD103(+) Dendritic Cell Progenitors at the Tumor Site Enhances Tumor Responses to Therapeutic PD-L1 and BRAF Inhibition.
暂无分享,去创建一个
F. Ginhoux | A. Palucka | M. Merad | M. Bosenberg | Adeeb H. Rahman | S. Gnjatic | Navpreet Tung | Hélène Salmon | N. Bhardwaj | D. Hashimoto | J. Brody | M. Leboeuf | R. Remark | S. Chakarov | J. Idoyaga | Stefan Jordan | M. Casanova-Acebes | Makhzuna Khudoynazarova | Christina Rivera | Brandon Hogstad | Brian D. Brown | Judith Agudo